LabCorp Diagnostics CEO resigns less than month after being named to role

//LabCorp Diagnostics CEO resigns less than month after being named to role

LabCorp Diagnostics CEO resigns less than month after being named to role

John Ratliff resigned as chief executive officer of LabCorp Diagnostics (NYSE: LH) on Nov. 1, the company announced Wednesday. Ratliff’s new role had been announced less than a month earlier and was set to take effect the day he stepped down. Before being named CEO of LabCorp Diagnostics last month, Ratliff was CEO of Covance. Both companies are owned by Laboratory Corporation of America Holdings, which is based in Burlington. Ratliff was promoted as part of a restructuring of leadership roles…

Article by [author-name] (c) Health Care News - Health Care News Headlines | Bizjournals.com - Read full story here.

By | 2019-11-07T00:06:51+00:00 November 7th, 2019|Healthcare|

About the Author: